Default company panoramic image
56111543 a395 45b6 bbcf cebcb6c9c746

Sanguina, LLC

Sanguina has developed AnemoCheck and AnemoCheck Mobile, a new, disruptive point-of-care and in-home system that detects anemia in an inexpensive, simpler way.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Atlanta, GA, US
  • Currency USD
  • Founded 2014
  • Employees 8
  • Incorporation Type LLC
  • Website sanguina.com

Company Summary


Sanguina was established to develop and market AnemoCheck, a screening device, which is a rapid, accurate, inexpensive and disposable point-of-care test for anemia. It has been developed and extensively tested and should be available for marketing in early 2016.
Anemia is a major health concern, affecting approximately 2 billion people (30% of the world's population) annually. Anemia often co-exists with other disease states.

Team

  • 8f4ad36b abfe 45ae 9a5f 39ed839772df
    Co-Founder

    Tom Stribling has a 30 year record in the health industry. Companies he led have traditionally reached successful and profitable liquidity through sale to larger corporations. Prior to the current venture he started three other companies; one as a new division of a major chemical corp.; a second at the request of a leading VC firm and another that he conceived, privately funded, grew and sold to a major foreign corp. in less than four years.

  • Default avatar
    Wilbur Lam, M.D., Ph.D.
    Co-founder and Medical Director

    Dr. Lam is Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, and is an Assistant Professor in the Department of Pediatrics, Division of hematology/Oncology at Emory University School of Medicine. He leads an interdisciplinary laboratory based at Georgia Tech and Emory dedicate to developing new diagnostic techniques for hematologic and childhood disorders.

  • Default avatar
    Erika Tyburski
    Co-founder and CEO

    Ms. Tyburski began working on AnemoCheck in her senior year of undergraduate school at the Georgia Institute of Technology. After graduating with a bachelor's of science in Biomedical Engineering from Tech in 2012, she joined Dr. Wilbur Lam's laboratory based at Emory and Georgia Tech and continues to conduct prototype development, interference and stability studies and clinical assessments on the product.

  • E28f8455 23e2 4d4f 9a49 ca085a3ac810
    Vice President, Chemistry

    Dr. Lyon is Professor of Chemistry and Dean of the Schmid College of Science and Technology at Chapman University in Orange, CA, and is an analytical/materials/physical chemist who has developed new bioanalytical tools for ~17 years. He has extensive experience in redox chemistry and dye-mediated electron transfer systems such as those utilized in AnemoCheck, which he helped characterize and optimize

  • Default avatar
    Tom Stribling
    Co-Founder

    Tom Stribling has a 30 year record in the health industry. Companies he led have traditionally reached successful and profitable liquidity through sale to larger corporations. Prior to the current venture he started three other companies; one as a new division of a major chemical corp.; a second at the request of a leading VC firm and another that he conceived, privately funded, grew and sold to a major foreign corp. in less than four years.

  • Default avatar
    Rene Gonzalez
    CFO

Advisors

  • Default avatar
    Siobhan O'Connor, M.D.
    Global Health Advisor to Sanguina Dr. O'Connor is a Senior Medical Officer for Global Health at the Center for Disease Control and Prevention (CDC), in Atlanta, GA.
    Unconfirmed